Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateM&A4d ago

Parmax Pharma Ltd

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").

Parmax Pharma Ltd has received a letter of offer from Fedex Securities Pvt Ltd, the manager to the offer, for the acquisition of up to 23,46,250 equity shares, representing 26% of the expanded voting capital, by Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with 10 persons acting in concert, at a price of ₹42.80 per equity share.

Read more →📎 1 attachment
BSECompany Update4d ago

Transgene Biotek Ltd

Statement of Deviation & Variation

Transgene Biotek Ltd has submitted a statement of deviation and variation for the quarter ended June 30, 2026, stating that no public issue, rights issue, or preferential issue occurred during the period, making the submission of the statement not applicable.

Read more →📎 1 attachment
BSEBoard MeetingResults4d ago

UFO Moviez India Ltd

UFO Moviez India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve UFO Moviez India Ltd has informed ....

UFO Moviez India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 28/07/2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026.

Read more →📎 1 attachment
BSECompany UpdateResults4d ago

Infobeans Technologies Ltd

Financial Results- Signed Consolidated Limited Review Report

Infobeans Technologies Ltd has released its unaudited standalone financial results for the quarter ended June 30, 2026, as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's management is responsible for the preparation of the financial results, and the auditor has conducted a review to express an opinion on the accuracy of the financial statements.

Read more →📎 1 attachment
BSEOthers4d ago

Transgene Biotek Ltd

Compliance -57 (5)

Transgene Biotek Ltd has informed that Regulation 57(5) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended June 30, 2026, as no non-convertible securities were issued.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion4d ago

HFCL Ltd

Setting up of a state-of-the-art manufacturing facility for Data Center Connectivity Products: Details as attached letter.

HFCL Ltd has announced the setting up of a state-of-the-art manufacturing facility for Data Center Connectivity Products with a capacity of 2,70,000 assemblies per annum at an estimated capital outlay of ₹215 crore. The decision is driven by the significant growth in global demand for data center connectivity products.

Read more →📎 1 attachment
BSECompany UpdateRegulatory4d ago

LG Electronics India Ltd

Newspaper Publication regarding Public Notice published before sending Notice of AGM and Annual Report

LG Electronics India Ltd has published a public notice through newspaper advertisements in Financial Express and Jansatta before sending the notice of its upcoming Annual General Meeting (AGM) and Annual Report to its members. The AGM is scheduled to be held on August 21, 2026, through video conferencing or other audio-visual means.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveExpansion4d ago

HFCL Ltd

Outcome of Board Meeting - 22.07.2026

HFCL Ltd has announced the outcome of its Board Meeting held on July 22, 2026, where the Board approved the setting up of a state-of-the-art manufacturing facility for Data Center Connectivity Products with a capacity of 2,70,000 assemblies per annum at an estimated capital outlay of ₹215 crore. The company also announced its unaudited financial results for the 1st Quarter ended June 30, 2026, on a standalone and consolidated basis.

Read more →📎 1 attachment
← PreviousPage 186 of 335Next →